BioSpace News Archive

Policy

Trump Administration Halts Fetal Tissue Research at NIH

While the NIH research has been impacted, HHS said no research conducted outside of the NIH, which includes universities conducting research under NIH grants, will be affected at this time.

June 6, 2019
·
2 min read
·
Alex Keown
Business

Third Rock Venture to Seed Life Science Companies with $770 Million Fund

This is the largest fund in the 12 years Third Rock has been in existence. The company indicates it will use the money to seed 10 to 12 life science companies.

June 6, 2019
·
3 min read
·
Mark Terry
Novartis’ Iscalimab Could Improve Lifespan of Kidney Transplants

Typically, fewer than half of kidney transplants last 10 years. As a result, durability is definitely a significant unmet need for patients who have had a transplant or are waiting to receive one.

June 6, 2019
·
3 min read
·
Mark Terry
Drug Development

Takeda Discontinues Amyloidosis Study Following Phase III Failure

Takeda said that patients treated with Ninlaro in the Phase III TOURMALINE-AL1 study failed to see a significant improvement in overall hematologic response.

June 6, 2019
·
2 min read
·
Alex Keown
BioMidwest

New Research May Bring Novel Approaches to Treating and Preventing Tuberculosis

Globally, TB is the leading cause of death by an infectious disease. It is caused by a bacterium, Mycobacterium tuberculosis.

June 6, 2019
·
3 min read
·
Mark Terry
Novartis presents first-of-its-kind histology data with iscalimab (CFZ533) suggesting the extended survival of transplanted organs may be possible

Novartis announced = new early stage histology data in kidney transplantation, suggesting that with investigational compound iscalimab (CFZ533) it may be possible to prolong the durability of transplanted kidneys as well as to potentially improve long-term outcomes for kidney transplant patients

June 6, 2019
·
6 min read
LNC Therapeutics announces the deployment of a research platform focused exclusively on its gut microbiome activities

LNC Therapeutics, a French biotech company specializing in gut microbiome-based drug research and development, announced the deployment of a research platform focused exclusively on its gut microbiome activities and more precisely on analysis of the therapeutic properties of christensenella.

June 6, 2019
·
3 min read
Business

Gavi, NEC, and Simprints to Deploy World’s First Scalable Child Fingerprint Identification Solution to Boost Immunization in Developing Countries

Gavi, the Vaccine Alliance, NEC Corporation, and Simprints Technology Ltd. have signed a memorandum of understanding on the use of biometrics to improve immunization coverage in developing countries.

June 6, 2019
·
5 min read
Business

Arcutis, Inc. Appoints Scott Burrows as Vice President, Finance

Arcutis, Inc. announced the appointment of Scott Burrows as Vice President, Finance.

June 6, 2019
·
1 min read
Pharm Country

Final Day of BIO International Convention Begins in Philadelphia

Thursday programming will emphasize personalized medicine for oncology, rare disease clinical trials and biotech venture capitalism

June 6, 2019
·
3 min read